StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2021 it was -0.35 CAD.

Annual eps

PeriodPeriod endValueChange
FY2021Mar 31, 2021-0.35 CAD–
FY2020Mar 31, 2020-0.26 CAD–

More Medicenna Therapeutics figures

See a number that looks wrong?